CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 700	$ 872
Accounts receivable, net of allowance for credit losses of $29 and $31 as of September 30, 2022 and December 31, 2021, respectively	1,280	1,438
Inventories	183	208
Prepaid expenses and other current assets	171	223
Total current assets	2,334	2,741
Property, plant and equipment, net	1,707	1,707
Operating lease right-of-use assets	607	597
Goodwill	7,190	7,095
Intangible assets, net	1,115	1,167
Investments in equity method investees	138	141
Other assets	132	163
Total assets	13,223	13,611
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	1,447	1,600
Current portion of long-term debt	2	2
Current portion of long-term operating lease liabilities	153	151
Total current liabilities	1,602	1,753
Long-term debt	3,980	4,010
Long-term operating lease liabilities	505	494
Other liabilities	787	792
Commitments and contingencies
Redeemable noncontrolling interest	77	79
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2022 and December 31, 2021; 162 shares issued as of both September 30, 2022 and December 31, 2021	2	2
Additional paid-in capital	2,272	2,260
Retained earnings	8,263	7,649
Accumulated other comprehensive loss	(31)	(14)
Treasury stock, at cost; 48 and 43 shares as of September 30, 2022 and December 31, 2021, respectively	(4,271)	(3,453)
Total Quest Diagnostics stockholders' equity	6,235	6,444
Noncontrolling interests	37	39
Total stockholders' equity	6,272	6,483
Total liabilities and stockholders' equity	$ 13,223	$ 13,611